Using long-range freeze-preventive vaccine carriers in Nepal: A study of equipment performance, acceptability, systems fit, and cost.

AHW, auxiliary health worker ANM, auxiliary nurse midwife BPKIHS, B.P. Koirala Institute of Health Sciences CCH, cold chain handler Cold chain equipment FPVC, freeze-preventive vaccine carrier Freeze-preventive vaccine carrier HP, health post Immunization Innovation MKT, mean kinetic temperature MOHP, Ministry of Health and Population N/A, not applicable PQS, Performance, Quality and Safety SVC, standard vaccine carrier VVM, vaccine vial monitor Vaccine cold chain Vaccine freezing WHO, World Health Organization

Journal

Vaccine: X
ISSN: 2590-1362
Titre abrégé: Vaccine X
Pays: England
ID NLM: 101748769

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 07 05 2021
accepted: 07 02 2022
entrez: 4 3 2022
pubmed: 5 3 2022
medline: 5 3 2022
Statut: epublish

Résumé

Preventing vaccine freezing is one of the biggest challenges in vaccine management. Until 2018, vaccine carriers used in the immunization program lacked features to prevent vaccine freezing. Freeze-preventive vaccine carriers (FPVCs) have an engineered liner that buffers vaccines from direct exposure to frozen ice packs. A field evaluation of three FPVCs was conducted in 24 health posts in eastern Nepal. The objective was to evaluate the FPVCs' performance, acceptability, systems fit, and cost, to inform prequalification and introduction planning. The study was carried out in two phases: in the first phase, FPVCs containing dummy vaccines (labeled "Not for Human Use") were transported to outreach sessions along with a standard vaccine carrier (SVC); in the second phase, the FPVCs were used for transporting vaccines taken to outreach sessions and used for vaccinating eligible children. The study gathered quantitative and qualitative data from health workers, logbooks, and electronic temperature monitors placed inside and outside the FPVCs. Results indicate the FPVCs successfully prevented temperatures below 0 °C more than 99% of the time-except at one site, where ambient temperatures were below the minimum rated testing temperature specified by the World Health Organization. Internal cool-down times for the FPVCs were highly variable, as were mean kinetic temperatures, possibly driven by the wide range of ambient temperatures and higher-than-expected variations in freezer performance, which, along with the need to transport ice packs to some locations, affected ice-pack temperatures. Almost all health workers requested smaller, lighter-weight FPVCs but appreciated the FPVCs' ability to prevent vaccines from freezing while avoiding undue heat exposure. FPVCs had benefit-cost ratios greater than 1 and hence good value for money. Results point to the importance of understanding the intended environment of use and the need for smaller, short-range as well as long-range carriers.

Identifiants

pubmed: 35243322
doi: 10.1016/j.jvacx.2022.100146
pii: S2590-1362(22)00006-7
pmc: PMC8867128
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100146

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Vaccine. 2007 May 16;25(20):3980-6
pubmed: 17382434
Vaccine. 2018 Jan 2;36(1):128-133
pubmed: 29174313
Vaccine. 2007 Jan 26;25(7):1328-33
pubmed: 17157419
Bull World Health Organ. 2010 Aug 1;88(8):624-31
pubmed: 20680128
Vaccine. 2017 Apr 19;35(17):2127-2133
pubmed: 28364920
Prev Med. 2004 Aug;39(2):384-8
pubmed: 15226050

Auteurs

Sandeep Kumar (S)

PATH, New Delhi, India.

Pat Lennon (P)

PATH, Seattle, WA, USA.

Nancy Muller (N)

PATH, Seattle, WA, USA.

Surendra Uranw (S)

B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

Mercy Mvundura (M)

PATH, Seattle, WA, USA.

Alexandra Sibole (A)

PATH, Seattle, WA, USA.

Steven Diesburg (S)

PATH, Seattle, WA, USA.

Joe Little (J)

PATH, Seattle, WA, USA.

Arindam Ray (A)

Bill & Melinda Gates Foundation, India Country Office, New Delhi, India.

Jhalak Sharma Gautam (J)

Government of Nepal, Family Health Division, Ministry of Health and Population, Kathmandu, Nepal.

Rupa Rajbhandari Singh (R)

B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

Nilambar Jha (N)

B.P. Koirala Institute of Health Sciences, Dharan, Nepal.

Classifications MeSH